Literature DB >> 16131569

Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.

Leticia H Nolasco1, Nancy A Turner, Aubrey Bernardo, Zhenyin Tao, Thomas G Cleary, Jing-Fei Dong, Joel L Moake.   

Abstract

Shiga toxin 1 (Stx-1) and Stx-2 produced by enterohemorrhagic Escherichia coli cause the diarrhea-associated hemolytic uremic syndrome (HUS). This type of HUS is characterized by obstruction of the glomeruli and renal microvasculature by platelet-fibrin thrombi, acute renal failure, thrombocytopenia, microvascular hemolytic anemia, and plasma levels of von Willebrand factor (VWF)-cleaving protease (ADAMTS13) activity that are within a broad normal range. We investigated the mechanism of initial platelet accumulation on Stx-stimulated endothelial cells. Stx-1 or Stx-2 (1-10 nM) stimulated the rapid secretion of unusually large (UL) VWF multimeric strings from human umbilical vein endothelial cells (HUVECs) or human glomerular microvascular endothelial cells (GMVECs). Perfused normal human platelets immediately adhered to the secreted ULVWF multimeric strings. Nanomolar concentrations (1-10 nM) of the Shiga toxins were as effective in inducing the formation of ULVWF-platelet strings as millimolar concentrations (0.1-20 mM) of histamine. The rate of ULVWF-platelet string cleavage by plasma or recombinant ADAMTS13 was delayed by 3 to 10 minutes (or longer) in the presence of 10 nM Stx-1 or Stx-2 compared with 20 mM histamine. Stx-induced formation of ULVWF strings, and impairment of ULVWF-platelet string cleavage by ADAMTS13, may promote initial platelet adhesion above glomerular endothelial cells. These processes may contribute to the evolution of glomerular occlusion by platelet and fibrin thrombi in diarrhea-associated HUS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131569      PMCID: PMC1895236          DOI: 10.1182/blood-2005-05-2111

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  77 in total

1.  Decrease of thrombomodulin contributes to the procoagulant state of endothelium in haemolytic uraemic syndrome.

Authors:  Julie M Williams; C Mark Taylor
Journal:  Pediatr Nephrol       Date:  2005-02       Impact factor: 3.714

2.  Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress.

Authors:  A Bernardo; C Ball; L Nolasco; H Choi; J L Moake; J F Dong
Journal:  J Thromb Haemost       Date:  2005-03       Impact factor: 5.824

3.  The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome.

Authors:  H Uchida; N Kiyokawa; H Horie; J Fujimoto; T Takeda
Journal:  Pediatr Res       Date:  1999-01       Impact factor: 3.756

4.  Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2.

Authors:  N Kiyokawa; T Taguchi; T Mori; H Uchida; N Sato; T Takeda; J Fujimoto
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

5.  Unrecognized pattern of von Willebrand factor abnormalities in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.

Authors:  M Galbusera; A Benigni; S Paris; P Ruggenenti; C Zoja; C Rossi; G Remuzzi
Journal:  J Am Soc Nephrol       Date:  1999-06       Impact factor: 10.121

Review 6.  Coagulation changes associated with the hemolytic uremic syndrome.

Authors:  N Gordjani; A H Sutor
Journal:  Semin Thromb Hemost       Date:  1998       Impact factor: 4.180

7.  Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.

Authors:  L L Cooling; K E Walker; T Gille; T A Koerner
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; E C Lian
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

9.  von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

Authors:  M Furlan; R Robles; M Galbusera; G Remuzzi; P A Kyrle; B Brenner; M Krause; I Scharrer; V Aumann; U Mittler; M Solenthaler; B Lämmle
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

10.  Shiga toxin 1 elicits diverse biologic responses in mesangial cells.

Authors:  M Simon; T G Cleary; J D Hernandez; H E Abboud
Journal:  Kidney Int       Date:  1998-10       Impact factor: 10.612

View more
  56 in total

1.  Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice.

Authors:  Jing Huang; David G Motto; David R Bundle; J Evan Sadler
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

2.  Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.

Authors:  Fang Liu; Jing Huang; J Evan Sadler
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

Review 3.  Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.

Authors:  Minola Manea; Diana Karpman
Journal:  Pediatr Nephrol       Date:  2008-09-20       Impact factor: 3.714

Review 4.  Thrombotic microangiopathies: multimers, metalloprotease, and beyond.

Authors:  Joel Moake
Journal:  Clin Transl Sci       Date:  2009-10       Impact factor: 4.689

Review 5.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

6.  Interaction of Shiga toxin with the A-domains and multimers of von Willebrand Factor.

Authors:  Nathan C Lo; Nancy A Turner; Miguel A Cruz; Joel Moake
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

Review 7.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

8.  Decreased severity of Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS) in a child with type 1 von Willebrand disease.

Authors:  Matthew A Geramita; Johannes Hofer; James Cooper; Michael L Moritz
Journal:  BMJ Case Rep       Date:  2017-08-30

Review 9.  Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Ramon Alfonso Exeni; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Gabriela Alejandra Fiorentino; Andrea Mariana Exeni; Maria Victoria Ramos; Marina Sandra Palermo
Journal:  Pediatr Nephrol       Date:  2018-01-25       Impact factor: 3.714

10.  Down-regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopenia.

Authors:  Ya-Lan Guo; Dan-Qing Liu; Zhen Bian; Chen-Yu Zhang; Ke Zen
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.